# FDA Inspection 1223277 - Apex360, LLC - November 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/apex360-llc/709063a2-a2df-4838-858b-9a0f4dfbdf27
Source feed: FDA_Inspections

> FDA Inspection 1223277 for Apex360, LLC on November 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223277
- Company Name: Apex360, LLC
- Inspection Date: 2023-11-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1069143 - 2018-10-17](https://www.keypedia.com/records/fda_inspections/apex360-llc/9bafbbd8-1b0f-4d3a-ad93-140cc04d717d)
- [FDA Inspection 983399 - 2016-07-07](https://www.keypedia.com/records/fda_inspections/apex360-llc/1c42772e-682f-485c-ad37-81d3875103a3)
- [FDA Inspection 714985 - 2011-03-11](https://www.keypedia.com/records/fda_inspections/apex360-llc/7a63e960-41d1-449f-837a-055b77ddfa5b)

Company: https://www.keypedia.com/companies/apex360-llc/fad5c7ea-1a2c-4b95-bd36-041efce3c503

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c